VEON's subsidiary plans investor meetings for a potential offering of unsecured medium-term notes to optimize capital structure.
Quiver AI Summary
VEON Ltd. announced that its subsidiary, VEON MidCo B.V., has begun a series of investor meetings for a potential offering of unsecured US dollar medium-term notes in two tranches, one maturing in five years and another in seven years. The proceeds from this offering are intended to extend VEON’s average debt maturity and will be used to purchase up to $750 million of its outstanding Senior Notes due 2027, which have a total outstanding principal of approximately $1.014 billion. The remaining funds will be allocated for further debt reduction and general corporate purposes. VEON, which provides digital services to over 150 million customers across five countries, is listed on NASDAQ, and this offering is restricted in the United States and the UK. Forward-looking statements regarding the offering are included, emphasizing the associated risks and uncertainties.
Potential Positives
- VEON’s proposed offering of medium-term notes aims to extend the average debt maturity, which could improve the company's financial stability and flexibility.
- The anticipated use of proceeds from the offering to purchase outstanding senior notes is a proactive move towards optimizing the company's capital structure, potentially leading to reduced debt costs.
- VEON is actively engaging with investors through meetings, indicating a strategic approach to raising capital and strengthening investor relations.
- The company’s digital services reach over 228 million users across several countries, illustrating its significant market presence and potential for growth.
Potential Negatives
- The company is attempting to manage its debt load through a significant bond offering, indicating potential liquidity issues or financial strain.
- There is no assurance that the notes will be issued, raising concerns about the company's ability to successfully execute this financing strategy.
- The Offering is targeted only to specific professional investors, limiting the potential investor base and indicating a lack of broader market confidence.
FAQ
What is the purpose of VEON's recent offering of medium-term notes?
VEON's offering aims to extend its average debt maturity and optimize its capital structure.
What will the proceeds from the notes be used for?
The proceeds will primarily fund the purchase of outstanding 2027 Notes and support debt reduction and corporate purposes.
What are the terms of the medium-term notes being offered?
The offering includes two tranches: a five-year non-callable for two years and a seven-year non-callable for three years.
Who can participate in the notes offering?
The notes are only available to relevant persons, such as investment professionals and high net worth entities.
Where can I find more information about VEON?
More information about VEON is available on their official website at https://www.veon.com/.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$VEON Hedge Fund Activity
We have seen 43 institutional investors add shares of $VEON stock to their portfolio, and 63 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VR ADVISORY SERVICES LTD added 293,481 shares (+293.0%) to their portfolio in Q1 2026, for an estimated $13,588,170
- HELIKON INVESTMENTS LTD removed 168,416 shares (-32.8%) from their portfolio in Q4 2025, for an estimated $8,853,629
- MORGAN STANLEY added 111,685 shares (+17.0%) to their portfolio in Q1 2026, for an estimated $5,171,015
- MILLENNIUM MANAGEMENT LLC removed 108,862 shares (-79.6%) from their portfolio in Q1 2026, for an estimated $5,040,310
- PICTET ASSET MANAGEMENT HOLDING SA removed 63,956 shares (-28.3%) from their portfolio in Q1 2026, for an estimated $2,961,162
- HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND removed 54,427 shares (-99.0%) from their portfolio in Q1 2026, for an estimated $2,519,970
- PANVIEW CAPITAL LTD added 42,685 shares (+8.3%) to their portfolio in Q1 2026, for an estimated $1,976,315
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Full Release
Dubai and New York, May 18, 2026 – VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON” or the “Company”), today announces that its subsidiary VEON MidCo B.V. has initiated a series of investor meetings in connection with a potential offering (the “Offering”) of unsecured US dollar medium term notes in two tranches: a five-year tranche, non-callable for two years, and a seven-year tranche, non-callable for three years (together, the “Notes”).
The Offering is expected to extend VEON’s average debt maturity and, together with the concurrent tender offer described below, support the Company's ongoing optimization of its capital structure.
The Company intends to use the net proceeds from the Offering to fund the purchase its outstanding 3.375% Senior Notes due 2027 (the "2027 Notes") for an aggregate purchase price of up to USD 750 million, pursuant to a tender offer launched today. The 2027 Notes have an outstanding principal amount of USD 1,013,973,000 (Regulation S Global Note ISIN: XS2824764521; Rule 144A Global Note ISIN: XS2824766146). Any remaining net proceeds are expected to support additional debt reduction and general corporate purposes.
About VEON
VEON is a digital operator that provides connectivity and digital services to over 150 million connectivity customers and more than 228 million digital users. Operating across five countries that are home to more than 6% of the world’s population, VEON is transforming lives through technology-driven services that empower individuals and drive economic growth. VEON is listed on NASDAQ. For more information, visit:
https://www.veon.com/
.
This announcement is not an offer of securities for sale into the United States. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States, except pursuant to an applicable exemption from registration. No public offering of securities is being made in the United States.
Contact Information
VEON media inquiries
[email protected]
Cautionary Statement
There is no assurance that the notes will be issued or, if issued, as to the terms under which they will be issued.
Promotion of the notes in the United Kingdom is restricted by the Financial Services and Markets Act 2000 (the “FSMA”), and accordingly, the notes are not being promoted to the general public in the United Kingdom. This announcement is only addressed to and directed at persons who (i) are investment professionals, as such term is defined in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the “Financial Promotion Order”), (ii) are persons falling within Article 49(2)(a) to (d) (“high net worth companies, unincorporated associations, etc.”) of the Financial Promotion Order, (iii) are outside the United Kingdom or (iv) are persons to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the FSMA) in connection with the issue or sale of any securities may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as “relevant persons”).
The notes will only be available to relevant persons and this announcement must not be acted on or relied on by anyone who is not a relevant person.
Manufacturer target market (MIFID II/UK MiFIR product governance) is eligible counterparties and professional clients only (all distribution channels). No PRIIPs key information document (KID) has been prepared as not available to retail investors in EEA or the United Kingdom.
Disclaimer
This press release contains “forward-looking statements,” as the phrase is defined in Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended, including in relation to VEON’s intended use of proceeds from its planned notes issue. These forward-looking statements generally are identified by the words “expect,” “will,” “will be,” and similar expressions (including the negative versions of such words or expressions).
By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors because they relate to events and depend on circumstances that may or may not occur in the future. Readers are cautioned that forward-looking statements are not guarantees of future performance and are based on numerous assumptions and that the Group’s or any of its affiliates’ actual results of operations.